Dysbiosis Contributes to Fibrogenesis in the Course of Chronic Liver Injury in Mice

被引:248
作者
De Minicis, Samuele [1 ]
Rychlicki, Chiara [1 ]
Agostinelli, Laura [1 ]
Saccomanno, Stefania [1 ]
Candelaresi, Cinzia [1 ]
Trozzi, Luciano [1 ]
Mingarelli, Eleonora [1 ]
Facinelli, Bruna [2 ]
Magi, Gloria [2 ]
Palmieri, Claudio [2 ]
Marzioni, Marco [1 ]
Benedetti, Antonio [1 ]
Svegliati-Baroni, Gianluca [1 ,2 ,3 ]
机构
[1] Univ Politecn Marche, Dept Gastroenterol, I-60020 Ancona, Italy
[2] Univ Politecn Marche, Microbiol Sect, Dept Biomed Sci & Publ Hlth, I-60020 Ancona, Italy
[3] Obes Study Ctr, Ancona, Italy
关键词
CORE GUT MICROBIOME; FATTY LIVER; METABOLIC SYNDROME; BACTERIAL TRANSLOCATION; INSULIN-RESISTANCE; INNATE IMMUNITY; DISEASE; OBESITY; STEATOHEPATITIS; ACTIVATION;
D O I
10.1002/hep.26695
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Nonalcoholic fatty liver disease (NAFLD) may lead to hepatic fibrosis. Dietary habits affect gut microbiota composition, whereas endotoxins produced by Gram-negative bacteria stimulate hepatic fibrogenesis. However, the mechanisms of action and the potential effect of microbiota in the liver are still unknown. Thus, we sought to analyze whether microbiota may interfere with liver fibrogenesis. Mice fed control (CTRL) or high-fat diet (HFD) were subjected to either bile duct ligation (BDL) or CCl4 treatment. Previously gut-sterilized mice were subjected to microbiota transplantation by oral gavage of cecum content obtained from donor CTRL- or HFD-treated mice. Fibrosis, intestinal permeability, bacterial translocation, and serum endotoxemia were measured. Inflammasome components were evaluated in gut and liver. Microbiota composition (dysbiosis) was evaluated by Pyrosequencing. Fibrosis degree was increased in HFD+BDL versus CTRL+BDL mice, whereas no differences were observed between CTRL+CCl4 and HFD+CCl4 mice. Culture of mesenteric lymph nodes showed higher density of infection in HFD+BDL mice versus CTRL+BDL mice, suggesting higher bacterial translocation rate. Pyrosequencing revealed an increase in percentage of Gram-negative versus Gram-postive bacteria, a reduced ratio between Bacteroidetes and Firmicutes, as well as a dramatic increase of Gram-negative Proteobacteria in HFD+BDL versus CTRL+BDL mice. Inflammasome expression was increased in liver of fibrotic mice, but significantly reduced in gut. Furthermore, microbiota transplantation revealed more liver damage in chimeric mice fed CTRL diet, but receiving the microbiota of HFD-treated mice; liver damage was further enhanced by transplantation of selected Gram-negative bacteria obtained from cecum content of HFD+BDL-treated mice. Conclusions: Dietary habits, by increasing the percentage of intestinal Gram-negative endotoxin producers, may accelerate liver fibrogenesis, introducing dysbiosis as a cofactor contributing to chronic liver injury in NAFLD.
引用
收藏
页码:1738 / 1749
页数:12
相关论文
共 38 条
  • [1] Nonalcoholic fatty liver disease
    Brunt, Elizabeth M.
    Wong, Vincent W. -S.
    Nobili, Valerio
    Day, Christopher P.
    Sookoian, Silvia
    Maher, Jacquelyn J.
    Bugianesi, Elisabetta
    Sirlin, Claude B.
    Neuschwander-Tetri, BrentA.
    Rinella, Mary E.
    [J]. NATURE REVIEWS DISEASE PRIMERS, 2015, 1
  • [2] The gut microbiota as an environmental factor that regulates fat storage
    Bäckhed, F
    Ding, H
    Wang, T
    Hooper, LV
    Koh, GY
    Nagy, A
    Semenkovich, CF
    Gordon, JI
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (44) : 15718 - 15723
  • [3] Non-alcoholic steatohepatitis-induced fibrosis: Toll-like receptors, reactive oxygen species and Jun N-terminal kinase
    Brenner, David A.
    Seki, Ekihiro
    Taura, Kojiro
    Kisseleva, Tatiana
    Deminicis, Samuele
    Iwaisako, Keiko
    Inokuchi, Sayaka
    Schnabl, Bernd
    Oesterreicher, Christopher H.
    Paik, Yong H.
    Miura, Kouichi
    Kodama, Yuzo
    [J]. HEPATOLOGY RESEARCH, 2011, 41 (07) : 683 - 686
  • [4] Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms
    Bugianesi, E
    Gastaldelli, A
    Vanni, E
    Gambino, R
    Cassader, M
    Baldi, S
    Ponti, V
    Pagano, G
    Ferrannini, E
    Rizzetto, M
    [J]. DIABETOLOGIA, 2005, 48 (04) : 634 - 642
  • [5] Bacterial translocation of enteric organisms in patients with cirrhosis
    Cirera, I
    Bauer, TM
    Navasa, M
    Vila, J
    Grande, L
    Taurá, P
    Fuster, J
    García-Valdecasas, JC
    Lacy, A
    Suárez, MJ
    Rimola, A
    Rodés, J
    [J]. JOURNAL OF HEPATOLOGY, 2001, 34 (01) : 32 - 37
  • [6] Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications
    Cusi, Kenneth
    [J]. GASTROENTEROLOGY, 2012, 142 (04) : 711 - U109
  • [7] Gene expression profiles during hepatic stellate cell activation in culture and in vivo
    De Minicis, Samuele
    Seki, Ekihiro
    Uchinami, Hiroshi
    Kluwe, Johannes
    Zhang, Yonghui
    Brenner, David A.
    Schwabe, Robert F.
    [J]. GASTROENTEROLOGY, 2007, 132 (05) : 1937 - 1946
  • [8] Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase Mediates Fibrotic and Inflammatory Effects of Leptin on Hepatic Stellate Cells
    De Minicis, Samuele
    Seki, Ekjhiro
    Oesterreicher, Christoph
    Schnabl, Bernd
    Schwabe, Robert F.
    Brenner, David A.
    [J]. HEPATOLOGY, 2008, 48 (06) : 2016 - 2026
  • [9] Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases
    Duboc, Henri
    Rajca, Sylvie
    Rainteau, Dominique
    Benarous, David
    Maubert, Marie-Anne
    Quervain, Elodie
    Thomas, Ginette
    Barbu, Veronique
    Humbert, Lydie
    Despras, Guillaume
    Bridonneau, Chantal
    Dumetz, Fabien
    Grill, Jean-Pierre
    Masliah, Joelle
    Beaugerie, Laurent
    Cosnes, Jacques
    Chazouilleres, Olivier
    Poupon, Raoul
    Wolf, Claude
    Mallet, Jean-Maurice
    Langella, Philippe
    Trugnan, Germain
    Sokol, Harry
    Seksik, Philippe
    [J]. GUT, 2013, 62 (04) : 531 - 539
  • [10] CURRENT CONCEPTS Hepatocellular Carcinoma
    El-Serag, Hashem B.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (12) : 1118 - 1127